These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6451462)

  • 1. The inhibition of islet superoxide dismutase by diabetogenic drugs.
    Crouch RK; Gandy SE; Kimsey G; Galbraith RA; Galbraith GM; Buse MG
    Diabetes; 1981 Mar; 30(3):235-41. PubMed ID: 6451462
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
    Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
    J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structural and enzymatic changes in the islets of the rat pancreas following alloxan and streptozotocin administration].
    Hettwer H; Dahlmann B; Marjanovic SD
    Cell Mol Biol Incl Cyto Enzymol; 1978; 23(4):355-67. PubMed ID: 162617
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of inhibition of calcium- and calmodulin-dependent protein kinase by alloxan.
    Norling LL; Colca JR; Brooks CL; Kloepper RF; McDaniel ML; Landt M
    Biochim Biophys Acta; 1984 Sep; 801(2):197-205. PubMed ID: 6236851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemiluminescence as an index of drug-induced free radical production in pancreatic islets.
    Asayama K; English D; Slonim AE; Burr IM
    Diabetes; 1984 Feb; 33(2):160-3. PubMed ID: 6229439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet cell membrane alteration by diabetogenic drugs.
    Orci L; Amherdt M; Malaisse-Lagae F; Ravazzola M; Malaisse WJ; Perrelet A; Renold AE
    Lab Invest; 1976 May; 34(5):451-4. PubMed ID: 131879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozocin- and alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets. H2O2 as mediator for DNA fragmentation.
    Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
    Diabetes; 1991 Sep; 40(9):1141-5. PubMed ID: 1834504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin.
    Yamamoto H; Uchigata Y; Okamoto H
    Biochem Biophys Res Commun; 1981 Dec; 103(3):1014-20. PubMed ID: 6460502
    [No Abstract]   [Full Text] [Related]  

  • 11. Superoxide dismutase in low-dose-streptozocin-treated mice. A dynamic time-course study.
    Papaccio G; Latronico M; Frascatore S; Pisanti FA
    Int J Pancreatol; 1991; 10(3-4):253-60. PubMed ID: 1838564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against streptozotocin-induced diabetes by superoxide dismutase.
    Robbins MJ; Sharp RA; Slonim AE; Burr IM
    Diabetologia; 1980 Jan; 18(1):55-8. PubMed ID: 6444904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective role of copper-zinc superoxide dismutase against alloxan-induced diabetes: morphological aspects.
    Thaete LG; Crouch RK; Buse MG; Spicer SS
    Diabetologia; 1985 Sep; 28(9):677-82. PubMed ID: 3905479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloxan, but not streptozotocin, increases blood perfusion of pancreatic islets in rats.
    Jansson L; Sandler S
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E57-63. PubMed ID: 1386190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diethyldithiocarbamate on diabetogenic action of alloxan in rats.
    Kurahashi M; Masui H; Yoshimoto S; Wakabayashi I; Sakamoto K
    Diabetes Res Clin Pract; 1993 Jan; 19(1):39-47. PubMed ID: 8386078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antioxidant probucol prevents development of alloxan diabetes and decrease of antioxidant enzyme activity in rat tissues].
    Korchin VI; Lankin VZ; Iarkova RD; Konovalova GG; Smirnov LD; Kukharchuk VV
    Biull Eksp Biol Med; 1992 Sep; 114(9):279-82. PubMed ID: 1477358
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of streptozotocin on erythrocyte and retinal superoxide dismutase.
    Crouch R; Kimsey G; Priest DG; Sarda A; Buse MG
    Diabetologia; 1978 Jul; 15(1):53-7. PubMed ID: 150354
    [No Abstract]   [Full Text] [Related]  

  • 18. Superoxide dismutase activity in the BB rat: a dynamic time-course study.
    Pisanti FA; Frascatore S; Papaccio G
    Life Sci; 1988; 43(20):1625-32. PubMed ID: 3057304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of superoxide dismutase activities in isolated rat and guinea pig islets of Langerhans.
    Gorray KC; Sorresso D; Moak SA; Maimon J; Greenwald RA; Schneider BS
    Horm Metab Res; 1993 Dec; 25(12):649-50. PubMed ID: 8119673
    [No Abstract]   [Full Text] [Related]  

  • 20. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse.
    Grankvist K; Marklund SL; Täljedal IB
    Biochem J; 1981 Nov; 199(2):393-8. PubMed ID: 7041886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.